Clinical Trial

A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated October 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase III, multicenter, randomized, double-masked, Active-controlled design. The aims to confirm previous findings of the efficacy and safety of CsA-PG Ophthalmic Gel by comparing it to CsA Ophthalmic Gel for treating dry eye symptoms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-16.
Trial Details
NCT Number NCT06942793
Lead Sponsor Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Conditions Dry Eye Disease
Enrollment 396 participants
Start Date 2025-05-20
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-29